Researchers report that asprosin, a hunger hormone released by fat tissue, stays elevated after weight loss, which could help explain why lost pounds come back.
Recap by typeshit. Full story at Firstpost.
18:20
Dr. Lindsay Ogle, an MD who covers metabolic health, talks through options for people whose appetite hasn't settled on GLP-1 treatment.
A short post credits scientists with finding axolotl peptides that kill breast cancer cells. It names no study or team, so treat it as an early claim.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
Gottlieb also covers the FDA's new Rare Disease Framework Initiative and the latest on the measles outbreak in the CNBC interview.
The obesity specialist says the drugs act on inflammation directly, not just through weight loss, and that benefits fade when patients stop taking them.
Loading…